Tudor Investment Corp’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-820
Closed -$67K 1366
2017
Q3
$67K Buy
+820
New +$67K ﹤0.01% 1019